The Bulletin
The Times


.

Immuno Cure Deploys Scientist Team to Manage Research Facility for Therapeutic DNA Vaccine for HIV at Center of International Innovation for Technology and Science

  • Written by The Bulletin

Another significant step towards the success of ICVAX®

HONG KONG SAR - Media OutReach Newswire - 27 May 2026 - Immuno Cure Group ("Immuno Cure"), headquartered at Hong Kong Science Park, is pleased to announce the inauguration of the research facility for its HIV therapeutic DNA vaccine ("ICVAX®") at the Center of International Innovation for Technology and Science ("CIITS") located in Hetao, Shenzhen.

Read more: Immuno Cure Deploys Scientist Team to Manage Research Facility for Therapeutic DNA Vaccine for HIV...

hacklink hack forum hacklink film izle hacklink online casinoHitbetonline casinos australiaaustralian online casinosHitbethitbetroyal reels casino australiaroyalreels.pokerbetpipojojobetVipparkz_libraryjojobetสล็อตสล็อตvipparkgrandpashabetstakeBetpipoVipparkjojobetroyalbetPadişahbetjojobetjojobetdamabetPadişahbetDizipalPadişahbetGalabetmostbetholiganbetTuloskeskusmarsbahismarsbahiskralbetkralbetmeritking